Alliqua, Inc. (NASDAQ:ALQA)

CAPS Rating: 1 out of 5

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

6 Outperform
29 Underperform
 

All-Star Players

2 Outperform
22 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top ALQA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

jed71 (99.52)
Submitted September 16, 2014

I actually remember seeing this issue’s name (Alliqua) from a few years ago. It took me awhile to figure out how I know the name but after a bit of research I found some old promotional activity by this company back in 2011. Here is a small amount of… More

ALQA VS S&P 500 (SPY)

ALQA Summary

Recent Community Commentary

Read the most recent pitches from players about ALQA.

Recs

0
Member Avatar SmartAce (99.96) Submitted: 2/13/2018 12:35:01 PM : Underperform Start Price: $1.70 ALQA Score: -24.36

For a mountain to be called Kilimanjaro, it needs to kill at least 1 manjaro.

Recs

0
Member Avatar rhallbick (97.22) Submitted: 1/5/2018 3:33:55 PM : Underperform Start Price: $1.93 ALQA Score: -10.10

The last 10-Q (Sept, 2017) shows 4,986,034 outstanding common shares, up from 2,966,904 at the beginning of 2017. They had $7.8 million in current assets and $1.7 million in improvements & equipment versus $16.7 million in current liabilities. Their Selling, General and Administrative (S,G & A) expenses come in at about twice their gross profit, so they lose $20 million or more per year from continuing operations. Cumulative retained earnings were up to a negative $138 million. These results do not deter them from awarding millions of dollars of stock-based compensation to management every year.

The $12.1 million remaining on a secured term loan is due for complete repayment on Jan 31, 2018. They generally have been selling blocks of shares in the $3.50 to $5.00 range, but more recently the stock market price has been under $2 per share, so they need to sell more than 6 million shares to cover the debt payment, plus perhaps more to cover operating losses. Two members of the Board of Directors have recently resigned. Their number one risk is their "ability to continue as a going concern;". It should be an interesting and volatile January for their stock.

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/2/2017 6:10:43 AM : Outperform Start Price: $6.20 ALQA Score: -79.11

tissue regeneration technology for wounds. Celgene owns a 10% stake in the company.

Leaderboard

Find the members with the highest scoring picks in ALQA.

Score Leader

TMFBabo

TMFBabo (100.00) Score: +283.01

The Score Leader is the player with the highest score across all their picks in ALQA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
LarkinSoft 99.82 1/15/2016 Underperform 5Y $16.90 -87.16% +46.82% +133.98 0 Comment
TheDumbMoney2 97.39 1/14/2015 Underperform NS $52.00 -95.83% +36.92% +132.75 0 Comment
ziggystraw 99.11 9/17/2014 Underperform 5Y $50.00 -95.66% +36.38% +132.04 0 Comment
EvanBuck 99.93 9/17/2014 Underperform 5Y $49.60 -95.62% +36.34% +131.97 0 Comment
Slickrick9565 53.10 2/10/2016 Underperform 5Y $14.50 -85.03% +46.65% +131.68 0 Comment
jasonrivera < 20 1/13/2016 Underperform 5Y $16.85 -87.12% +44.46% +131.58 0 Comment
NobleOrSomeBull 99.44 1/19/2016 Underperform 5Y $16.60 -86.93% +43.91% +130.84 0 Comment
PunktBewiesen 67.63 3/6/2015 Underperform 5Y $53.10 -95.91% +30.35% +126.26 0 Comment
DigDeepAnalytics 98.60 12/23/2014 Underperform 5Y $41.90 -94.82% +31.32% +126.14 0 Comment
OptimistPrime2 96.60 3/5/2015 Underperform 5Y $54.15 -95.99% +29.91% +125.90 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ALQA.

Featured Broker Partners